-
-biased IL-2), and ALX-148/evorpacept (an ultra-high affinity SIRPa decoy). Moreover, the Ring Lab is actively working on developing platforms for identifying new targets in cancer immunotherapy
-
infections of varying severities. Define features of effective and ineffective antigen targets in the T cell repertoire and develop in vitro and in vivo models to test features of diverse immune specificities
-
ineffective antigen targets and develop in vitro and in vivo models to test features of diverse immune specificities. Participate and engage in institutional, division, and the lab's principal investigator's
-
T cell receptor specificity analysis, to define features of effective and ineffective antigen targets and develop in vitro and in vivo models to test features of diverse immune specificities
-
seeking a highly qualified and motivated Post-Doctoral Research Fellow. The project will study molecular pathogenesis and therapeutic strategies associated with two promising cell cycle targets in head and
-
at identifying novel therapeutic targets and developing new combination treatment strategies. Responsibilities Design and execute independent research projects under the mentorship of Dr. Li. Apply for independent